[Chronic lymphocytic leukemias].
Imamura
N
N
Department of Hematology & Oncology, Division of Clinical Research, Research Institute for Radiation Medicine & Biology, Hiroshima University.
D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000145:classification / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D011379:Prognosis; D012737:Sex Factors; D015996:Survival Rate / Q000639:trends; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
D014740:Vidarabine; C024352:fludarabine